Delayed heart failure medications after fixing the cause
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether starting two heart failure medications later, after a procedure to fix the heart's problem, is safe and helpful. It aims to see if waiting a bit can still improve heart function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your heart's pumping ability was low (40% or less) before a procedure to fix a heart problem, like valve repair or bypass surgery.
- You had a successful procedure to fix the cause of your heart failure, such as valve surgery or opening blocked arteries.
- You are enrolled between 3 months before and 10 days after that procedure.
- You are stable after the procedure, with no need for strong IV medications to support your heart.
- If you were already on these heart failure medications, you must stop them for 1 week before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients whose heart function has fully recovered after surgery or a heart procedure can safely reduce or stop their heart failure medications. Researchers will carefully monitor whether gradually lowering these medicines is safe and maintains heart health.
This trial tests whether it is safe to slowly reduce some heart failure medications for people whose heart function has improved to normal. It is for patients who once had a weak heart pump but now have recovered strength and are stable on multiple medicines.
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
This study tests whether increasing the doses of standard heart failure medicines shortly after a catheter-based heart valve procedure improves recovery and long-term heart function. It is designed for people with heart failure who had a valve fixed during this hospital stay.
This trial looks at how starting new heart failure treatments affects your body's metabolism. It may be an option if you have stable heart failure and haven't taken certain newer medicines before.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.